• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症治疗中的神经认知及其影响因素——阿立哌唑、奥氮平、喹硫平和利培酮的作用

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.

作者信息

Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Engel R R, Müller N, Möller H-J, Spellmann I

机构信息

Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.

出版信息

Hum Psychopharmacol. 2010 Mar;25(2):116-25. doi: 10.1002/hup.1101.

DOI:10.1002/hup.1101
PMID:20196179
Abstract

BACKGROUND

To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment.

METHODS

Data were obtained from patients with an acute episode of schizophrenia participating in two double-blind and one open label trial comparing the effects of different atypical antipsychotics on cognition. In total, 129 patients were enrolled in this analysis. Cognitive function was assessed at admission, week 4 and 8. Efficacy and tolerability were assessed weekly using the Positive and Negative Syndrome Scale (PANSS) and the Simpson Angus Sale (SAS). Patients were treated with aripirazole, olanzapine, quetiapine and risperidone. Regression analysis including mixed effect models was performed.

RESULTS

A significant improvement in all cognitive domains was observed from baseline to week 8. Regarding the antipsychotic treatment applied quetiapine seemed to achieve the most favourable cognitive improvement. Negative and depressive symptoms, the patient's age and the concomitant and antipsychotic treatment applied were observed to significantly influence and predict neurocognition.

CONCLUSION

The results may indicate that schizophrenia is a static disorder with trait and state dependent cognitive components especially in the memory domains. The influence of negative and depressive symptoms should be considered in daily clinical routine.

摘要

背景

研究精神分裂症患者神经认知的影响变量,并预测抗精神病治疗期间的认知情况。

方法

数据来自参与两项双盲试验和一项开放标签试验的精神分裂症急性发作患者,这些试验比较了不同非典型抗精神病药物对认知的影响。本分析共纳入129例患者。在入院时、第4周和第8周评估认知功能。每周使用阳性和阴性症状量表(PANSS)和辛普森·安格斯量表(SAS)评估疗效和耐受性。患者接受阿立哌唑、奥氮平、喹硫平和利培酮治疗。进行了包括混合效应模型的回归分析。

结果

从基线到第8周,所有认知领域均有显著改善。就应用的抗精神病治疗而言,喹硫平似乎取得了最有利的认知改善。观察到阴性和抑郁症状、患者年龄以及应用的联合和抗精神病治疗对神经认知有显著影响并可进行预测。

结论

结果可能表明,精神分裂症是一种具有特质和状态依赖性认知成分的静态疾病,尤其是在记忆领域。在日常临床工作中应考虑阴性和抑郁症状的影响。

相似文献

1
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.精神分裂症治疗中的神经认知及其影响因素——阿立哌唑、奥氮平、喹硫平和利培酮的作用
Hum Psychopharmacol. 2010 Mar;25(2):116-25. doi: 10.1002/hup.1101.
2
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.利培酮对精神分裂症和分裂情感性障碍的认知及精神运动作用。
Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014.
3
Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.从口服非典型抗精神病药物换用长效注射用利培酮对精神分裂症患者认知功能的影响。
Hum Psychopharmacol. 2009 Oct;24(7):565-73. doi: 10.1002/hup.1057.
4
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.利培酮和喹硫平对精神分裂症伴显著阴性症状患者认知功能的影响。
Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. doi: 10.1007/s00406-007-0739-x. Epub 2007 Jul 14.
5
Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.接受常规治疗的慢性精神分裂症患者中齐拉西酮的神经认知效应及相关因素:一项为期12个月的开放标签、灵活剂量、自然观察性试验。
Clin Neuropharmacol. 2008 Jul-Aug;31(4):204-20. doi: 10.1097/WNF.0b013e3181572781.
6
Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.长效利培酮治疗精神分裂症的安全性和有效性:一项针对从典型及非典型口服抗精神病药物转换而来的稳定患者进行的为期12周的多中心开放标签研究。
J Clin Psychiatry. 2004 Aug;65(8):1084-9.
7
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.氯氮平与利培酮联合治疗精神分裂症患者的双盲研究:对认知的影响。
J Clin Psychiatry. 2006 Dec;67(12):1912-9.
8
Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.抗精神病药第一代和第二代药物对早期精神分裂症的神经认知影响:一项自然随访 12 个月的研究。
Neurosci Lett. 2011 Oct 3;503(2):141-6. doi: 10.1016/j.neulet.2011.08.027. Epub 2011 Aug 24.
9
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.卡巴拉汀治疗作为精神分裂症和认知缺陷患者抗精神病药物的附加治疗。
Curr Med Res Opin. 2007 Mar;23(3):575-83. doi: 10.1185/030079906X167372.
10
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.

引用本文的文献

1
Quetiapine Moderates Doxorubicin-Induced Cognitive Deficits: Influence of Oxidative Stress, Neuroinflammation, and Cellular Apoptosis.喹硫平缓解多柔比星诱导的认知障碍:氧化应激、神经炎症和细胞凋亡的影响。
Int J Mol Sci. 2023 Jul 16;24(14):11525. doi: 10.3390/ijms241411525.
2
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.Dysbindin-1 的变异与抗精神病药物治疗的认知反应有关。
Nat Commun. 2018 Jun 11;9(1):2265. doi: 10.1038/s41467-018-04711-w.
3
A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia.
阿立哌唑与利培酮治疗精神分裂症的短期疗效比较研究。
Curr Neuropharmacol. 2017 Nov 14;15(8):1073-1084. doi: 10.2174/1570159X15666170113100611.
4
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement.急性精神病中神经认知变化的过程:与症状改善的关系。
PLoS One. 2016 Dec 15;11(12):e0167390. doi: 10.1371/journal.pone.0167390. eCollection 2016.
5
An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.对健康志愿者在工作记忆过程中阿立哌唑在背外侧前额叶皮质内的部分 D₂ 激动剂作用的一项研究。
Psychopharmacology (Berl). 2016 Apr;233(8):1415-26. doi: 10.1007/s00213-016-4234-9. Epub 2016 Feb 22.
6
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.首发精神分裂症谱系障碍中认知与临床反应的关系。
Schizophr Bull. 2015 Nov;41(6):1237-47. doi: 10.1093/schbul/sbv120. Epub 2015 Sep 25.
7
Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.用于比较新型第二代药物治疗精神分裂症方法的系统文献综述:聚焦于卫生技术评估
Pharmacoeconomics. 2015 Oct;33(10):1049-67. doi: 10.1007/s40273-015-0285-8.
8
Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).喹硫平在双相情感障碍中的作用超越其临床疗效:从神经保护到精神疾病治疗(综述)
Exp Ther Med. 2015 Mar;9(3):643-652. doi: 10.3892/etm.2015.2213. Epub 2015 Jan 23.
9
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.喹硫平对因治疗反应不足而从其他抗精神病药物转换过来的精神分裂症患者的长期疗效和耐受性——一项前瞻性开放标签研究。
Ann Gen Psychiatry. 2015 Jan 22;14(1):1. doi: 10.1186/s12991-014-0039-6. eCollection 2015.
10
Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients.首发未经药物治疗的精神分裂症患者应用非典型抗精神病药物的认知效应。
Neural Regen Res. 2013 Jan 25;8(3):277-86. doi: 10.3969/j.issn.1673-5374.2013.03.011.